PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Solar cell compound probed under pressure

Solar cell compound probed under pressure
2014-09-25
(Press-News.org) Washington, D.C.— Gallium arsenide, GaAs, a semiconductor composed of gallium and arsenic is well known to have physical properties that promise practical applications. In the form of nanowires and nanoparticles, it has particular potential for use in the manufacture of solar cells and optoelectronics in many of the same applications that silicon is commonly used.

But the natural semiconducting ability of GaAs requires some tuning in order to make it more desirable for use in manufacturing these types of products. New work from a team led by Carnegie's Alexander Goncharov explores a novel approach to such tuning. Their work is published in Scientific Reports. The research team includes Wei Zhou, Xiao-Jia Chen, Xin-Hua Li and Yu-Qi Wang of the Chinese Academy of Sciences and Jian-Bo Zhang of South China University of Technology.

Metallic substances conduct electrical current easily, whereas insulating (non-metallic) materials conduct no current at all. Semiconducting materials exhibit mid-range electrical conductivity. When semiconducting materials are subjected to an input of a specific energy, bound electrons can be moved to higher-energy, conducting states. The specific energy required to make this jump to the conducting state is defined as the "band gap." Fine-tuning of this band gap has the potential to improve gallium arsenide's commercial potential.

There are different methods available to engineer slight tweaks to the "band gap." Goncharov's team focused on the novel application of very high pressure, which can cause a compound to undergo electronic changes that can alter the electron-carrier properties of materials. It had already been demonstrated on nanowires made from one crystalline form of gallium arsenide--the cubic so-called "zincblende" structure--that the "band gap" widens under pressure.

The present research focused instead on nanowires of a less-common crystalline form--the hexagonal so-called "wurtzite" structure. The team subjected "wurtzite" gallium arsenide to up to about 227,000 times normal atmospheric pressure (23 gigapascals) in diamond anvil cells. They discovered the "band gap" that the electrons need to leap across to also widened, although not as much as in the case of the "zincblende" crystal nanowires.

Significantly, they discovered that around 207,000 times normal atmospheric pressure (21 gigapascals), the "wurtzite" gallium arsenide nanowires underwent a structural change that induced a new phase, the so-called "orthorhombic" one, which may possibly have metallic electronic properties.

"The similarity in behavior when subjected to high pressure, but resulting in significant differences in the size of the 'band gap', between the two crystalline structures of gallium arsenide suggests that both types of GaAs structures could theoretically be incorporated into a single device, or even a single nanowire, and realize much more complex and useful electronic functions through interactions across the phases," Goncharov said. "We believe these findings will stimulate further research into gallium arsenide for both basic scientific and practical purposes." INFORMATION: This work was supported by NSFC, the U.S. ARO, DARPA. The GSECARS facility is supported by the NSF and DOE.

The Carnegie Institution for Science (carnegiescience.edu) is a private, nonprofit organization headquartered in Washington, D.C., with six research departments throughout the U.S. Since its founding in 1902, the Carnegie Institution has been a pioneering force in basic scientific research. Carnegie scientists are leaders in plant biology, developmental biology, astronomy, materials science, global ecology, and Earth and planetary science. END

[Attachments] See images for this press release:
Solar cell compound probed under pressure

ELSE PRESS RELEASES FROM THIS DATE:

A wriggly solution to a first-world problem

2014-09-25
Australian researchers have achieved groundbreaking results in a clinical trial using hookworms to reduce the symptoms of celiac disease. The results are also good news for sufferers of other inflammatory conditions such as asthma and Crohn's disease. In the small trial run over a year, 12 participants were each experimentally infected with 20 Necator americanus (hookworm) larvae. They were then given gradually increasing doses of gluten – beginning with just one-tenth of a gram per day (the equivalent of less than a one-inch segment of spaghetti) and increasing in ...

Study finds global sea levels rose up to 5 meters per century at the end of the last 5 ice ages

2014-09-25
Land-ice decay at the end of the last five ice-ages caused global sea-levels to rise at rates of up to 5.5 metres per century, according to a new study. An international team of researchers developed a 500,000-year record of sea-level variability, to provide the first account of how quickly sea-level changed during the last five ice-age cycles. The results, published in the latest issue of Nature Communications, also found that more than 100 smaller events of sea-level rise took place in between the five major events. Dr Katharine Grant, from the Australian National ...

Cryptogenic strokes may find explanation in the heart

2014-09-25
More than half of the patients who have suffered a stroke with no well-defined aetiology have an enlarged left atrial appendage of the heart, according to a Finnish study. The results indicate that the enlargement of the left atrial appendage may be an independent risk factor of strokes with cardiac origin. Mr Mikko Taina, Licentiate of Medicine, presented the results in his doctoral thesis at the University of Eastern Finland. Stroke is the leading cause of long-term disability and a major burden on health-care resources worldwide. Stroke is responsible for 10 per ...

Osteoarthritis of the hip: Appropriate exercise therapy can alleviate symptoms

2014-09-25
Osteoarthritis of the hip is a progressive degenerative disorder affecting the hip joints, which affects one in 10 adults. The symptoms range from pain after intense joint loading to morning pain/stiffness and impaired mobility in everyday life. To date, no cure exists. Appropriate exercise therapy can, however, delay progression of the disease and alleviate symptoms, as shown in a randomized controlled study reported by Inga Krauß et al in Deutsches Ärzteblatt (Dtsch Arztebl Int 2014; 111: 592–9). The physicians treated patients with hip osteoarthritis according to the ...

Human papilloma virus vaccination provides long-term protection

2014-09-25
Every year, 11.2 of every 100 000 women in Germany develop cervical cancer. Persistent infection with a high-risk human papillomavirus (HPV) type is a necessary prerequisite for the development of dysplasia and neoplasia of the cervix. HPV vaccination has been a subject of heated debate since it was incorporated into the vaccination recommendations of the German Standing Committee on Vaccination (STIKO) in 2007. This edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2014; 111: 584–91) reveals that Yvonne Deleré of Berlin's Robert Koch Institute et al. have ...

Brains not recognizing an angry expression

Brains not recognizing an angry expression
2014-09-25
Inattention, hyperactivity, and impulsive behavior in children with ADHD can result in social problems and they tend to be excluded from peer activities. They have been found to have impaired recognition of emotional expression from other faces. The research group of Professor Ryusuke Kakigi of the National Institute for Physiological Sciences, National Institutes of Natural Sciences, in collaboration with Professor Masami K. Yamaguchi and Assistant Professor Hiroko Ichikawa of Chuo University first identified the characteristics of facial expression recognition of children ...

Chemists recruit anthrax to deliver cancer drugs

2014-09-25
CAMBRIDGE, MA -- Bacillus anthracis bacteria have very efficient machinery for injecting toxic proteins into cells, leading to the potentially deadly infection known as anthrax. A team of MIT researchers has now hijacked that delivery system for a different purpose: administering cancer drugs. "Anthrax toxin is a professional at delivering large enzymes into cells," says Bradley Pentelute, the Pfizer-Laubauch Career Development Assistant Professor of Chemistry at MIT. "We wondered if we could render anthrax toxin nontoxic, and use it as a platform to deliver antibody ...

Scientists develop tool to help communities stay environmentally and socially 'healthy'

Scientists develop tool to help communities stay environmentally and socially healthy
2014-09-25
Geographers at the University of Southampton have developed a new way to measure the 'health' of poor regional communities. They aim to improve the wellbeing of people by guiding sustainable development practices to help avoid social and environmental collapse. The researchers have pioneered a methodology that examines the balance between factors such as; standards of living, natural resources, agriculture, industry and the economy. The results help identify critical limits, beyond which regions risk tipping into ecological and social downturn, or even collapse. The ...

Experts at LSTM use modelling approach to assess the effectiveness TB diagnostics

2014-09-25
Experts at LSTM have used a novel modelling approach to project the effects of new diagnostic methods and algorithms for the diagnosis of tuberculosis (TB) recently endorsed by the World Health Organization (WHO), looking at the patient, health system and population perspective in Tanzania. In a paper published in the journal The Lancet Global Health, LSTM's Ivor Langley and Professor Bertie Squire worked with colleagues from the Institute of Epidemiology and Preventative Medicine, National Taiwan University; National Tuberculosis and leprosy Programme, Tanzania; Department ...

Simple blood test could be used as tool for early cancer diagnosis

2014-09-25
High levels of calcium in blood, a condition known as hypercalcaemia, can be used by GPs as an early indication of certain types of cancer, according to a study by researchers from the universities of Bristol and Exeter. Hypercalcaemia is the most common metabolic disorder associated with cancer, occurring in 10 to 20 per cent of people with cancer. While its connection to cancer is well known, this study has, for the first time, shown that often it can predate the diagnosis of cancer in primary care. A simple blood test could identify those with hypercalcaemia, prompting ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Solar cell compound probed under pressure